Profiles

Keywords
Last Name
Institution

Nancy Reau

Concepts (232)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatitis C, Chronic
28
2021
83
9.860
Why?
Antiviral Agents
31
2021
139
8.960
Why?
Hepatitis C
18
2021
67
6.380
Why?
Hepacivirus
21
2021
73
5.040
Why?
Liver Transplantation
8
2021
110
3.640
Why?
Liver Diseases
9
2021
40
3.370
Why?
Pregnancy Complications, Infectious
3
2020
35
2.290
Why?
Ribavirin
9
2016
32
2.020
Why?
Pregnancy Complications
5
2019
57
1.930
Why?
Infectious Disease Transmission, Vertical
3
2020
20
1.860
Why?
Liver Cirrhosis
10
2019
61
1.660
Why?
Sulfonamides
7
2020
66
1.480
Why?
Hepatitis B
5
2019
20
1.470
Why?
Interferon-alpha
5
2012
82
1.410
Why?
Polyethylene Glycols
5
2012
57
1.410
Why?
Pregnancy
10
2021
452
1.380
Why?
Humans
56
2021
30741
1.250
Why?
Carbamates
9
2020
12
1.170
Why?
Quinoxalines
5
2020
11
1.100
Why?
Drug Therapy, Combination
13
2021
266
1.070
Why?
Treatment Outcome
20
2021
3850
0.970
Why?
Gastroenterology
3
2017
16
0.960
Why?
Liver Diseases, Alcoholic
2
2021
44
0.940
Why?
Living Donors
1
2021
16
0.920
Why?
Prejudice
1
2021
42
0.900
Why?
United States
16
2021
2467
0.890
Why?
Female
33
2021
18107
0.890
Why?
Thrombocytopenia
1
2020
31
0.850
Why?
Postoperative Hemorrhage
1
2020
30
0.840
Why?
Elective Surgical Procedures
1
2020
54
0.840
Why?
Benzimidazoles
3
2019
14
0.830
Why?
Patient Selection
1
2021
259
0.810
Why?
Kidney Transplantation
2
2018
144
0.800
Why?
Hypertension, Pregnancy-Induced
1
2019
2
0.790
Why?
Genotype
10
2017
447
0.780
Why?
Viral Load
5
2016
211
0.750
Why?
Algorithms
2
2020
421
0.730
Why?
Fear
1
2018
52
0.720
Why?
Cholestasis, Intrahepatic
3
2019
6
0.720
Why?
Obesity
1
2021
322
0.720
Why?
Adult
21
2021
9760
0.680
Why?
HIV Infections
3
2019
915
0.650
Why?
Drugs, Generic
1
2016
4
0.650
Why?
Antacids
1
2016
1
0.650
Why?
Proton Pump Inhibitors
1
2016
15
0.640
Why?
Pregnancy Complications, Neoplastic
1
2016
4
0.640
Why?
Virology
1
2015
16
0.620
Why?
Middle Aged
21
2021
11256
0.580
Why?
Patient Readmission
1
2016
124
0.560
Why?
Length of Stay
2
2016
371
0.550
Why?
Coinfection
3
2019
33
0.550
Why?
Young Adult
9
2021
2249
0.530
Why?
Preventive Health Services
1
2013
15
0.530
Why?
Mass Screening
5
2021
199
0.520
Why?
Advisory Committees
1
2013
43
0.510
Why?
Health Policy
1
2013
49
0.500
Why?
Cyclopropanes
4
2020
25
0.490
Why?
Heart Failure
1
2016
231
0.490
Why?
Male
23
2021
17552
0.480
Why?
Disease Management
2
2016
149
0.470
Why?
Liver
2
2018
216
0.460
Why?
Imidazoles
4
2020
74
0.430
Why?
Macrocyclic Compounds
4
2019
6
0.420
Why?
Pregnancy Outcome
2
2021
20
0.420
Why?
Recombinant Proteins
5
2012
308
0.420
Why?
Drug Resistance, Viral
4
2017
43
0.410
Why?
Bile Ducts, Intrahepatic
1
2008
7
0.370
Why?
Drug Administration Schedule
3
2018
271
0.360
Why?
Aged
14
2020
10156
0.360
Why?
Fatty Liver
2
2019
40
0.350
Why?
Anemia
1
2008
91
0.350
Why?
Retrospective Studies
8
2020
3456
0.340
Why?
Cohort Studies
6
2021
1959
0.340
Why?
Medication Adherence
2
2019
93
0.330
Why?
Liver Neoplasms
2
2019
128
0.320
Why?
Liver Function Tests
2
2019
32
0.320
Why?
Benzofurans
3
2020
8
0.310
Why?
Risk Factors
4
2020
2611
0.300
Why?
Graft Rejection
2
2018
85
0.300
Why?
Prevalence
2
2020
546
0.290
Why?
Societies, Medical
2
2017
203
0.280
Why?
Adolescent
4
2020
2627
0.280
Why?
Lactams, Macrocyclic
3
2019
9
0.280
Why?
Drug Interactions
2
2015
71
0.280
Why?
Proline
3
2019
20
0.280
Why?
Cost-Benefit Analysis
4
2021
146
0.280
Why?
Incidence
2
2020
827
0.270
Why?
Prospective Studies
4
2019
1891
0.260
Why?
Amides
2
2020
23
0.260
Why?
Risk Assessment
3
2018
804
0.260
Why?
Uracil
3
2019
5
0.260
Why?
Ritonavir
3
2019
18
0.250
Why?
Prognosis
3
2018
1045
0.250
Why?
Chronic Disease
3
2020
542
0.240
Why?
Selection Bias
1
2021
10
0.240
Why?
Fertility
1
2021
16
0.230
Why?
Aminoisobutyric Acids
2
2018
3
0.230
Why?
Leucine
2
2018
16
0.230
Why?
Graft Survival
2
2019
111
0.230
Why?
Pyrrolidines
2
2018
20
0.230
Why?
Hepatitis C Antibodies
1
2020
6
0.220
Why?
Aged, 80 and over
8
2020
5172
0.220
Why?
World Health Organization
1
2020
20
0.220
Why?
Tissue Donors
1
2021
74
0.220
Why?
End Stage Liver Disease
1
2020
17
0.210
Why?
Anilides
2
2019
11
0.210
Why?
Hemorrhage
1
2020
88
0.210
Why?
Recurrence
2
2011
390
0.210
Why?
Consensus
2
2021
96
0.200
Why?
Attitude of Health Personnel
1
2021
179
0.200
Why?
Drug and Narcotic Control
2
2016
8
0.200
Why?
Hyperemesis Gravidarum
1
2019
1
0.200
Why?
Hepatitis, Autoimmune
1
2019
8
0.200
Why?
Carcinoma, Hepatocellular
1
2019
46
0.200
Why?
Forecasting
1
2019
130
0.200
Why?
United States Food and Drug Administration
2
2016
78
0.190
Why?
Biomedical Research
1
2019
85
0.190
Why?
Transplant Recipients
1
2018
18
0.190
Why?
Internationality
1
2018
26
0.190
Why?
Logistic Models
2
2010
479
0.180
Why?
Follow-Up Studies
4
2015
2046
0.180
Why?
RNA, Viral
3
2018
170
0.180
Why?
Practice Guidelines as Topic
3
2021
389
0.180
Why?
Drug Substitution
1
2017
4
0.170
Why?
Critical Pathways
1
2017
23
0.170
Why?
Dose-Response Relationship, Drug
1
2018
527
0.170
Why?
Infant, Newborn
1
2019
751
0.170
Why?
Counterfeit Drugs
1
2016
2
0.160
Why?
Patient Participation
1
2017
51
0.160
Why?
Commerce
1
2016
11
0.160
Why?
Ascites
1
2016
5
0.160
Why?
Canada
1
2016
56
0.160
Why?
Paracentesis
1
2016
4
0.160
Why?
Quality Control
1
2016
48
0.160
Why?
Fraud
1
2016
15
0.160
Why?
Safety
1
2016
57
0.160
Why?
Psychometrics
1
2018
286
0.160
Why?
Interferons
1
2016
17
0.160
Why?
Eclampsia
1
2016
2
0.160
Why?
HELLP Syndrome
1
2016
2
0.160
Why?
Pre-Eclampsia
1
2016
8
0.160
Why?
Drug Approval
1
2016
34
0.160
Why?
Time Factors
3
2016
1911
0.160
Why?
Hydrogen-Ion Concentration
1
2016
175
0.160
Why?
Directive Counseling
1
2015
15
0.150
Why?
Benchmarking
1
2015
29
0.150
Why?
Diffusion of Innovation
1
2015
42
0.150
Why?
Hospitalization
2
2016
344
0.150
Why?
Benzazepines
1
2015
10
0.150
Why?
Isoquinolines
1
2015
17
0.150
Why?
Administration, Oral
1
2015
165
0.150
Why?
Deficiency Diseases
1
2015
2
0.150
Why?
Liver Failure
1
2015
13
0.150
Why?
Severity of Illness Index
1
2020
1233
0.150
Why?
Zinc
1
2015
39
0.150
Why?
Treatment Failure
2
2017
188
0.150
Why?
Indoles
1
2015
68
0.150
Why?
Kidney Failure, Chronic
1
2017
175
0.140
Why?
Comorbidity
4
2018
562
0.140
Why?
Phenotype
1
2015
368
0.140
Why?
Off-Label Use
1
2014
6
0.140
Why?
Hospitalists
1
2014
6
0.140
Why?
Randomized Controlled Trials as Topic
1
2016
361
0.140
Why?
African Americans
1
2021
780
0.140
Why?
Internship and Residency
1
2016
187
0.130
Why?
Multivariate Analysis
2
2015
391
0.130
Why?
Cooperative Behavior
1
2014
88
0.130
Why?
Health Care Costs
1
2014
82
0.130
Why?
Drug Eruptions
1
2013
18
0.130
Why?
Hematologic Diseases
1
2013
18
0.130
Why?
Viral Nonstructural Proteins
3
2017
9
0.130
Why?
Monitoring, Immunologic
1
2012
2
0.120
Why?
Quality of Health Care
1
2014
135
0.120
Why?
Gastrointestinal Diseases
1
2013
46
0.120
Why?
Drug Combinations
3
2017
88
0.120
Why?
Predictive Value of Tests
2
2017
631
0.120
Why?
Cost of Illness
1
2011
65
0.110
Why?
Drug Carriers
1
2010
9
0.110
Why?
Quality-Adjusted Life Years
2
2021
24
0.110
Why?
CD4-Positive T-Lymphocytes
1
2012
220
0.110
Why?
Models, Statistical
1
2011
146
0.100
Why?
Polymerase Chain Reaction
1
2010
209
0.100
Why?
Odds Ratio
1
2010
328
0.100
Why?
Sensitivity and Specificity
1
2011
594
0.100
Why?
Fluorenes
2
2019
3
0.090
Why?
Hemoglobins
1
2008
77
0.090
Why?
Valine
2
2019
11
0.090
Why?
Clinical Trials as Topic
1
2009
386
0.090
Why?
Cross-Sectional Studies
2
2021
957
0.080
Why?
Hospital Costs
2
2016
74
0.070
Why?
Pregnant Women
1
2021
13
0.060
Why?
Non-alcoholic Fatty Liver Disease
1
2019
4
0.050
Why?
Waiting Lists
1
2019
19
0.050
Why?
2-Naphthylamine
1
2019
3
0.050
Why?
Tissue and Organ Procurement
1
2019
36
0.050
Why?
Insurance, Major Medical
1
2018
1
0.050
Why?
International Normalized Ratio
1
2018
32
0.050
Why?
Registries
1
2019
203
0.050
Why?
High-Throughput Nucleotide Sequencing
1
2017
41
0.040
Why?
Uridine Monophosphate
1
2017
2
0.040
Why?
Genetic Variation
1
2017
117
0.040
Why?
Decision Support Techniques
1
2017
54
0.040
Why?
Delivery of Health Care, Integrated
1
2017
30
0.040
Why?
Serine Proteases
1
2016
7
0.040
Why?
Internal Medicine
1
2016
30
0.040
Why?
Career Choice
1
2016
32
0.040
Why?
Patient-Centered Care
1
2017
61
0.040
Why?
Cost Savings
1
2016
39
0.040
Why?
Pain Management
1
2018
140
0.040
Why?
Quality Indicators, Health Care
1
2016
44
0.040
Why?
Mental Disorders
1
2018
202
0.040
Why?
Patient Care Team
1
2017
143
0.040
Why?
Curriculum
1
2016
153
0.040
Why?
Early Diagnosis
1
2015
76
0.040
Why?
Reproducibility of Results
1
2018
875
0.040
Why?
Statistics, Nonparametric
1
2015
162
0.040
Why?
Hospital Mortality
1
2016
187
0.040
Why?
Kaplan-Meier Estimate
1
2015
230
0.030
Why?
Linear Models
1
2015
277
0.030
Why?
Databases, Factual
1
2016
372
0.030
Why?
Drug Industry
1
2014
30
0.030
Why?
Clinical Competence
1
2016
268
0.030
Why?
Guideline Adherence
1
2014
81
0.030
Why?
Acquired Immunodeficiency Syndrome
1
2014
101
0.030
Why?
Survival Rate
1
2015
478
0.030
Why?
Immunoassay
1
2012
44
0.030
Why?
Immunity, Cellular
1
2012
70
0.030
Why?
Inpatients
1
2014
147
0.030
Why?
Probability
1
2012
107
0.030
Why?
Disease Progression
1
2015
851
0.030
Why?
Immunosuppressive Agents
1
2012
167
0.030
Why?
Postoperative Complications
1
2012
1084
0.020
Why?
Reau's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description